Shopping Cart
Remove All
Your shopping cart is currently empty
SB 706504 is an effective p38 MAPK inhibitor that suppresses inflammatory gene expression in macrophages and inhibits TNFα production in LPS-stimulated chronic obstructive pulmonary disease (COPD).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $93 | - | In Stock | |
| 5 mg | $228 | - | In Stock | |
| 10 mg | $342 | - | In Stock | |
| 25 mg | $572 | - | In Stock | |
| 50 mg | $813 | - | In Stock |
| Description | SB 706504 is an effective p38 MAPK inhibitor that suppresses inflammatory gene expression in macrophages and inhibits TNFα production in LPS-stimulated chronic obstructive pulmonary disease (COPD). |
| In vitro | Methods: Alveolar macrophages (AMs) were treated with SB 706504 (3 μM, 0.5 hours), and the TNFα protein levels in the cell culture supernatant were analyzed using enzyme-linked immunoadsorption assay (ELISA). Results: SB 706504 significantly reduced the protein levels of TNFα.[1] |
| Synonyms | BLZ-945 hydrochloride, BLZ945 hydrochloride |
| Molecular Weight | 492.46 |
| Formula | C24H19F3N8O |
| Cas No. | 911110-38-8 |
| Smiles | O=C1N(C=2C(=C(N=C(NCCNC(NC#N)=N)N2)C3=C(C)C=C(F)C=C3)C=C1)C4=C(F)C=CC=C4F |
| Relative Density. | no data available |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: <49.25 mg/mL, Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.